Showing results (141-150 of 209) with videos related to
Sort By:
Pageof 21
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 1, 2026
Taming Autoimmunity: Alpha-1 Antitrypsin Overexpressing Mesenchymal Stem/Stromal Cells Promote Regulatory T Cell Crosstalk to Reverse DiabetesHua Wei, Wenyu Gou, Judong Kim, et al.Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|June 19, 2013
Prospective impact of illness uncertainty on outcomes in chronic lung diseaseKarin F Hoth, Frederick S Wamboldt, Matthew Strand, et al.Current Medical Research and Opinion|August 11, 2025
Prompt initiation of single-inhaler budesonide/glycopyrrolate/formoterol fumarate (BGF) following a COPD exacerbation reduces exacerbations and cardiopulmonary risk in patients with COPD: insights from the MITOS EROS+CP study in the United StatesMichael Pollack, Joseph Tkacz, Jill Schinkel, et al.Clinical Medicine Insights. Case Reports|August 27, 2015
Pleural Fluid Analysis in Chronic Hemothorax: A Mimicker of InfectionMatthew L DiVietro, John Terrill Huggins, Lauren Brown Angotti, et al.BMC Pulmonary Medicine|August 23, 2007
Design of the Endobronchial Valve for Emphysema Palliation Trial (VENT): a non-surgical method of lung volume reductionCharlie Strange, Felix J F Herth, Kevin L Kovitz, et al.COPD|September 15, 2015
Targeting Persons With or At High Risk for Chronic Obstructive Pulmonary Disease by State-based SurveillanceRoy A Pleasants, Khosrow Heidari, Anne G Wheaton, et al.BMC Clinical Pharmacology|October 6, 2010
Pharmacokinetic comparability of Prolastin®-C to Prolastin® in alpha₁-antitrypsin deficiency: a randomized studyJames M Stocks, Mark L Brantly, Laurene Wang-Smith, et al.Journal of Scleroderma and Related Disorders|December 2, 2024
Pathologic differences between systemic sclerosis-associated and idiopathic pulmonary arterial hypertensionSamuel H Friedman, Russell A Harley, Jacob Williams, et al.Respiratory Medicine|May 27, 2015
Body mass index, respiratory conditions, asthma, and chronic obstructive pulmonary diseaseYong Liu, Roy A Pleasants, Janet B Croft, et al.American Journal of Respiratory and Critical Care Medicine|January 31, 2009
Biologic lung volume reduction in advanced upper lobe emphysema: phase 2 resultsGerard J Criner, Victor Pinto-Plata, Charlie Strange, et al.Pageof 21